Quick Takeaways
- GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share (SWTX).
- Disclosed ownership: 0%.
- Date of event: 30 Sep 2025.
GOLDMAN SACHS GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share (SWTX)
- Filing Manager
- GOLDMAN SACHS GROUP INC
- Reporting Manager
- THE GOLDMAN SACHS GROUP, INC.
- Symbol
- SWTX
- Disclosed Ownership
- 132 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Nov 2025, 15:34:14 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GOLDMAN SACHS GROUP INC disclosed 0% ownership in SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $.0001 per share (SWTX) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 12 Nov 2025, 15:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 0% | 132 | 0 | 47 | Name: Sam Prashanth | Attorney-in-fact | |
| GOLDMAN SACHS & CO. LLC | 0% | 132 | 0 | 47 | Name: Sam Prashanth | Attorney-in-fact |